Anti-inflammatory agent
AssigneesUniversity of Strathclyde, The University Court of the University of Glasgow
InventorsWilliam Harnett, Margaret Harnett, Iain McInnes
Life of this patent
Estimating the term…
Abstract
This invention relates to the use of a phosphorylcholine-containing glycoprotein in the treatment or prophylaxis of diseases associated with inflammation. In particular, the present invention relates to the use of ES-62 for the treatment or prophylaxis of autoimmune diseases associated with abnormal inflammation, such as rheumatoid arthritis.
Claims12
Compound ES-62 or physiologically active derivatives thereof for use as a medicament.
Compound ES-62 or physiologically active derivatives thereof for use in the treatment or prophylaxis of inflammatory diseases in an animal.
Use of ES-62 or physiologically active derivatives thereof for the manufacture of a medicament for the treatment or prophylaxis of inflammatory diseases.
Method for the treatment or prophylaxis of inflammatory disease in an animal comprising administering to said animal a therapeutically or prophylactically effective amount of ES-62 or physiologically active derivatives thereof.
A pharmaceutical formulation comprising ES-62 or other physiologically active derivative thereof.
Dependencies are inferred from the claim text.